Form 4: Align Technology EVP Hockridge Reports Share Transactions

Align Technology's EVP of Global HR, Stuart A. Hockridge, reported the acquisition of 4,310 shares through equity vesting and the disposal of 1,210 shares for tax purposes.

Summary

• Stuart A. Hockridge, EVP, Global HR at Align Technology, Inc. (ALGN), reported transactions involving company common stock.
• On February 20, 2026, Hockridge acquired 4,310 shares of common stock through the vesting of various Restricted Stock Units (RSUs) and Market Stock Units (MSUs).
• Concurrently, 1,210 shares of common stock were disposed of at a price of $190.02 per share, typically to cover tax obligations related to the vesting.
• Following these transactions, Hockridge beneficially owns 14,892 shares of Align Technology common stock.
• The acquired shares include 419 shares from a 2024 RSU grant, 531 shares from a 2025 RSU grant, 227 shares from a 2022 RSU grant, 2,714 shares from a 2023 Market Stock Unit grant, and 419 shares from another 2023 RSU grant.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine and expected filing detailing executive equity compensation. The vesting of shares is a positive for the executive, while the tax-related disposal is a standard practice, indicating no significant new operational or financial developments for the company.

Positives

• Stuart A. Hockridge acquired 4,310 shares of common stock through the vesting of equity awards, indicating continued long-term incentive compensation.
• The vesting of Restricted Stock Units (RSUs) and Market Stock Units (MSUs) demonstrates the company's commitment to its executive compensation structure.

Negatives

• 1,210 shares of common stock were disposed of at $190.02 per share, likely to satisfy tax withholding obligations upon the vesting of equity awards, which reduces the direct beneficial ownership.

Future Outlook

The vesting schedules for some Restricted Stock Units indicate future annual vesting events, suggesting continued long-term incentive alignment for the reporting person.

Industry Context

StockSavvy.ai notes that routine Form 4 filings, such as this one, are common for executives receiving equity compensation. These transactions reflect standard compensation practices within the medical device and technology sectors, where long-term incentives like RSUs and MSUs are used to align executive interests with shareholder value over multi-year periods.

Comparison to Industry Standards

• StockSavvy.ai observes that the use of Restricted Stock Units (RSUs) and Market Stock Units (MSUs) for executive compensation is a standard practice across many industries, including medical technology.
• Companies like Johnson & Johnson, Medtronic, and Stryker frequently utilize similar equity-based incentive programs to retain talent and incentivize performance.
• The vesting schedules, typically over several years, are consistent with global benchmarks for executive long-term incentive plans, aiming to foster sustained commitment and performance.

Related Party Transactions

• The reported transactions involve the acquisition of common stock by an executive officer (Stuart A. Hockridge) through the vesting of equity awards granted by Align Technology, Inc., and the subsequent disposal of shares for tax purposes, which are standard related-party transactions within executive compensation frameworks.

Stakeholder Impact

• Shareholders: The vesting and subsequent tax-related sale of shares by an executive is a routine event and generally has a minimal direct impact on the broader shareholder base. It reflects the ongoing operation of the company's executive compensation plan.
• Employees: The filing highlights the company's use of equity compensation, which can be a positive signal for employee retention and motivation, particularly for those participating in similar plans.

Next Steps

• Remaining portions of the Restricted Stock Units granted on February 20, 2024, February 20, 2025, and February 20, 2023, will continue to vest annually.
• Shares will be delivered to the reporting person on each subsequent vest date.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation transactions (vesting and tax-related sales) and does not contain any new material information regarding the company's operational performance, financial health, or strategic direction. Therefore, it does not warrant a change in investment recommendation based solely on this filing. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Align Technology, ALGN, Stuart Hockridge, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, Market Stock Units, Equity Vesting, Executive Compensation, Share Ownership